Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis
Clinical trial NCT06041919 · TERMINATED
Trial details
- NCT number
- NCT06041919
- Sponsor
- Thirty Respiratory Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2024-07-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.